A phase II study of vinorelbine GIRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Guillem, V [1 ]
Muñoz, MA [1 ]
Yaya, R [1 ]
Soriano, V [1 ]
Climent, MA [1 ]
Gaspar, C [1 ]
机构：
[1] Inst Valenciano Oncol, Valencia, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81098-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
670
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [1] Results of a randomized phase II trial of docetaxel (TXT) with cisplatin (CDDP) or TXT with 5-fluorouracil (5FU) in patients (pts) with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Biakhov, M
    Betka, J
    Shah, P
    Julka, P
    Garin, A
    Stanculaneu, D
    Kawecki, A
    Miserque, D
    Blanc, C
    ANNALS OF ONCOLOGY, 2000, 11 : 92 - 92
  • [2] Phase I study of cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
    Humblet, Y
    Vega-Villegas, E
    Mesia, R
    Awada, A
    Geoffrois, L
    Borel, C
    Hitt, R
    Amellal, N
    Bessa, EH
    Bourhis, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 491S - 491S
  • [3] Phase I-II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Le Bouder, C
    Castelijns, J
    Awada, A
    Vermorken, JB
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S164 - S164
  • [4] A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Baghi, M
    Hambek, M
    Wagenblast, J
    May, A
    Wolfgang
    Gstoettner
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 585 - 590
  • [5] Phase I-II study with docetaxel (D), cisplatin (C) and 5-Fluorouracil (5-FU) in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Brandely, M
    Vermorken, JB
    ANNALS OF ONCOLOGY, 1998, 9 : 75 - 75
  • [6] Phase II trial of cisplatin (CDDP), 5-Fluorouracil (5Fu) and folinic acid (FA) for relapsing or metastatic squamous cell cancer of the head and neck (SCCHN)
    Vaz, F
    Oliveira, J
    Ferreira, M
    Torrinha, F
    Fernandes, A
    ANNALS OF ONCOLOGY, 1998, 9 : 79 - 79
  • [7] Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Degardin, M
    Bastit, P
    Rolland, F
    Armand, JP
    Chevallier, B
    VanGlabbeke, M
    Boudillet, J
    Tresca, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 843 - 843
  • [8] Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: A multicenter phase II trial
    Gebbia, V
    Mantovani, G
    Agostara, B
    Contu, A
    Farris, A
    Colucci, G
    Cognetti, F
    Restivo, G
    Speciale, R
    Ferrero, B
    Testa, A
    Curreli, L
    Cardinale, A
    Bajetta, E
    Gebbia, N
    ANNALS OF ONCOLOGY, 1995, 6 (10) : 987 - 991
  • [9] Phase II study of 5-fluorouracil (5-Fu), cisplatin (CDDP) and vinorelbine (VNR) in patients (pts) with advanced adenocarcinoma of oesophagus.
    Vicent, JM
    García-Girón, C
    Feliu, J
    Berrocal, A
    Camps, C
    Barón, G
    Lara, MA
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S76 - S76
  • [10] Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: A phase II randomized study
    Caponigro, F
    Rosati, G
    De Rosa, P
    Avallone, A
    De Rosa, V
    De Lucia, L
    Comella, P
    Comella, G
    ONCOLOGY, 2002, 63 (03) : 232 - 238
12345